Abstract
Purpose
The decision to undergo preimplantation genetic testing (PGT) entails a variety of personal and societal variables. Although PGT technology is widely accepted and used, few studies have queried the motives and concerns of PGT users; moreover, in-depth qualitative data regarding the PGT experience is scant.
Methods
In order to explore and analyze the experience, concerns, expectations, and attitudes toward the PGT technique and its implications, semi-structured interviews were conducted in a single tertiary medical center with 43 Israeli PGT users for HLA matching and autosomal dominant, autosomal recessive, and X-linked genetic disorders.
Results
The primary considerations in choosing PGT were prevention of birth of a child who would suffer a terminal or chronic disease as well as abrogation of a familial genetic condition. Religion played a decisive role in accepting PGT as an antenatal option. Regarding satisfaction with the PGT experience, many interviewees highlighted the need for greater attention to be given to potential stages of failure throughout the procedure and the need for emotional support.
Our clinical results regarding implantation rate and cumulative live birth rate are 38–40% and 27–30%, respectively.
Conclusion
This survey broadens understanding of the specialized needs of women, couples, and minority groups undergoing PGT and underscores the relevance of counseling services for PGT users.
Similar content being viewed by others
References
Handyside AH, Kontogianni EH, Hardy K, Winston RML. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990;344(6268):768–70.
Grazi RV, Wolowelsky JB. Cultural concerns when counseling orthodox Jewish couples for genetic screening and PGD. J Genet Couns. 2015;24(6):878–81.
Chamsi-Pasha H, Albar MA. Assisted reproductive technology: Islamic Sunni perspective. Hum Fertil (Camb). 2015;18(2):107–12.
Dreesen J, Destouni A, Kourlaba G, Degn B, Mette WC, Carvalho F, et al. Evaluation of PCR-based preimplantation genetic diagnosis applied to monogenic diseases: a collaborative ESHRE PGD consortium study. Eur J Hum Genet. 2014;22(8):1012–8.
Jiang Z, Wang Y, Lin J, Xu J, Ding G, Huang H. Genetic and epigenetic risks of assisted reproduction. Best Pract Res Clin Obstet Gynaecol. 2017;44:90–104.
Harper J, Geraedts J, Borry P, Cornel MC, Dondorp WJ, Gianaroli L, et al. Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. Hum Reprod. 2014;29(8):1603–9.
Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786–801.
Hershberger PE, Pierce PF. Conceptualizing couples’ decision making in PGD: emerging cognitive, emotional, and moral dimensions. Patient Educ Couns. 2010;81(1):53–62.
Karatas JC, Strong KA, Barlow-Stewart K, McMahon C, Meiser B, Roberts C. Psychological impact of preimplantation genetic diagnosis: a review of the literature. Reprod BioMed Online. 2010;20(1):83–91.
Cunningham J, Goldsmith L, Skirton H. The evidence base regarding the experiences of and attitudes to preimplantation genetic diagnosis in prospective parents. Midwifery. 2015;31(2):288–96.
Genoff Garzon MC, Rubin LR, Lobel M, Stelling J, Pastore LM. Review of patient decision-making factors and attitudes regarding preimplantation genetic diagnosis. Clin Genet. 2018;94(1):22–42.
Winkelman WD, Missmer SA, Myers D, Ginsburg ES. Public perspectives on the use of preimplantation genetic diagnosis. J Assist Reprod Genet. 2015;32(5):665–75.
Olesen AP, Nor SN, Amin L. Attitudes toward pre-implantation genetic diagnosis (PGD) for genetic disorders among potential users in Malaysia. Sci Eng Ethics. 2016;22(1):133–46.
Zierhut H, MacMillan ML, Wagner JE, Bartels DM. More than 10 years after the first ‘savior siblings’: parental experiences surrounding preimplantation genetic diagnosis. J Genet Couns. 2013;22(5):594–602.
Chan JL, Johnson LNC, Sammel MD, DiGiovanni L, Voong C, Domchek SM, et al. Reproductive decision-making in women with BRCA1/2 mutations. J Genet Couns. 2017;26(3):594–603.
Hallowell N, Badger S, Richardson S, Caldas C, Hardwick RH, Fitzgerald RC, et al. High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations. Familial Cancer. 2017;16(4):531–5.
Katz MG, Fitzgerald L, Bankier A, Savulescu J, Cram DS. Issues and concerns of couples presenting for preimplantation genetic diagnosis (PGD). Prenat Diagn. 2002;22(12):1117–22.
Lavery SA, et al. Preimplantation genetic diagnosis: patients’ experiences and attitudes. Hum Reprod. 2002;17(9):2464–7.
Roberts C, Franklin S. Experiencing new forms of genetic choice: findings from an ethnographic study of preimplantation genetic diagnosis. Hum Fertil (Camb). 2004;7(4):285–93.
Kalfoglou AL, Scott J, Hudson K. PGD patients’ and providers’ attitudes to the use and regulation of preimplantation genetic diagnosis. Reprod BioMed Online. 2005;11(4):486–96.
Dagan E, Birenbaum-Carmeli D, Friedman E, Feldman B. Performing and declining PGD: accounts of Jewish Israeli women who carry a BRCA1/2 mutation or partners of male mutation carriers. J Genet Couns. 2017;26(5):1070–9.
Haude K, McCarthy Veach P, LeRoy B, Zierhut H. Factors influencing the decision-making process and long-term interpersonal outcomes for parents who undergo preimplantation genetic diagnosis for Fanconi anemia: a qualitative investigation. J Genet Couns. 2017;26(3):640–55.
Klitzman R. Challenges, dilemmas and factors involved in PGD decision-making: providers’ and patients’ views. Experiences and Decisions J Genet Couns. 2018;27(4):909–19.
https://www.health.gov.il/Subjects/Med_Inst/IVF/Pages/IVF-list.aspx. Israeli Ministry of Health 2020.
http://call.health.gov.il/infocenter/index?page=content&id=EL7162. Israeli Ministry of Health. 2019.
Zlotogora J, Patrinos GP. The Israeli National Genetic database: a 10-year experience. Hum Genomics. 2017;11(1):5.
Zlotogora J, Grotto I, Kaliner E, Gamzu R. The Israeli national population program of genetic carrier screening for reproductive purposes. Genet Med. 2016;18(2):203–6.
Shalev, C. and S. Gooldin, The uses and misuses of in vitro fertilization in Israel: some sociological and ethical considerations. Nashim: A Journal of Jewish Women's Studies & Gender Issues, 2006: p. 151–176.
Birenbaum-Carmeli D. Thirty-five years of assisted reproductive technologies in Israel. Reprod Biomed Soc Online. 2016;2:16–23.
Bakst S, Romano-Zelekha O, Ostrovsky J, Shohat T. Determinants associated with making prenatal screening decisions in a national study. J Obstet Gynaecol. 2019;39(1):41–8.
David BE, Weitzman GA, Hervé C, Fellous M. Genetic counseling for the orthodox Jewish couple undergoing preimplantation genetic diagnosis. J Genet Couns. 2012;21(5):625–30.
Serour GI. Islamic perspectives in human reproduction. Reprod BioMed Online. 2008;17(Suppl 3):34–8.
Salemink S, Dekker N, Kets CM, van der Looij E, van Zelst-Stams WAG, Hoogerbrugge N. Focusing on patient needs and preferences may improve genetic counseling for colorectal cancer. J Genet Couns. 2013;22(1):118–24.
Tercyak KP, Johnson SB, Roberts SF, Cruz AC. Psychological response to prenatal genetic counseling and amniocentesis. Patient Educ Couns. 2001;43(1):73–84.
Lewis, C., H. Skirton, and R. Jones, Reproductive empowerment: the main motivator and outcome of carrier testing. J Health Psychol, 2011: p. 1359105311417193.
Teddlie C, Yu F. Mixed methods sampling a typology with examples. J Mixed Methods Res. 2007;1(1):77–100.
Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis (introducing qualitative methods series). London: SAGE Publications; 2006.
Shkedi A. Words of meaning: qualitative research-theory and practice (Hebrew). Tel-Aviv: Tel-Aviv university Ramot; 2003.
Zuckerman S, Zeevi DA, Gooldin S, Altarescu G. Acceptable applications of preimplantation genetic diagnosis (PGD) among Israeli PGD users. Eur J Hum Genet. 2017;25(10):1113–7.
Benagiano G, Carrara S, Filippi V. Robert G Edwards and the Roman Catholic Church. Reprod BioMed Online. 2011;22(7):665–72.
Derks-Smeets IA, et al. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Hum Reprod. 2014;29(5):1103–12.
Hashiloni-Dolev Y. Between mothers, fetuses and society: reproductive genetics in the Israeli-Jewish context. Nashim: A Journal of Jewish Women's Studies & Gender Issues. 2006;12(1):129–50.
Gooldin S. ‘Emotional rights’, moral reasoning, and Jewish-Arab alliances in the regulation of in-vitro-fertilization in Israel: theorizing the unexpected consequences of assisted reproductive technologies. Soc Sci Med. 2013;83:90–8.
Remennick L. The quest for the perfect baby: why do Israeli women seek prenatal genetic testing? Sociology of health & illness. 2006;28(1):21–53.
Harper J, et al. The ESHRE PGD consortium: 10 years of data collection. Hum Reprod Update. 2012;18(3):234–47.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zuckerman, S., Gooldin, S., Zeevi, D.A. et al. The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users. J Assist Reprod Genet 37, 1903–1912 (2020). https://doi.org/10.1007/s10815-020-01840-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-020-01840-4